Global Prescription Pain Medications Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Prescription Pain Medications Industry Forecast” looks at past sales and reviews total world Prescription Pain Medications sales in 2022, providing a comprehensive analysis by region and market sector of projected Prescription Pain Medications sales for 2023 through 2029. With Prescription Pain Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prescription Pain Medications industry.
This Insight Report provides a comprehensive analysis of the global Prescription Pain Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prescription Pain Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Prescription Pain Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prescription Pain Medications and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prescription Pain Medications.
The global Prescription Pain Medications market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Prescription Pain Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Prescription Pain Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Prescription Pain Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Prescription Pain Medications players cover Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Pain Medications market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Prescription Pain Medications market?
What factors are driving Prescription Pain Medications market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prescription Pain Medications market opportunities vary by end market size?
How does Prescription Pain Medications break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Prescription Pain Medications Industry Forecast” looks at past sales and reviews total world Prescription Pain Medications sales in 2022, providing a comprehensive analysis by region and market sector of projected Prescription Pain Medications sales for 2023 through 2029. With Prescription Pain Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prescription Pain Medications industry.
This Insight Report provides a comprehensive analysis of the global Prescription Pain Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prescription Pain Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Prescription Pain Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prescription Pain Medications and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prescription Pain Medications.
The global Prescription Pain Medications market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Prescription Pain Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Prescription Pain Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Prescription Pain Medications is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Prescription Pain Medications players cover Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Pain Medications market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Prescription NSAIDs
- Opioids
- Anti-epileptic Medicines
- Antidepressants
- Others
- Hospitals
- Clinics
- Drugstores
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- GSK
- Grunenthal
- Bayer
- Sanofi
- Eli Lilly
- AstraZeneca
- Endo
- Merck
- Depomed
- Teva
- J&J
- Allergan
What is the 10-year outlook for the global Prescription Pain Medications market?
What factors are driving Prescription Pain Medications market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prescription Pain Medications market opportunities vary by end market size?
How does Prescription Pain Medications break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prescription Pain Medications Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Prescription Pain Medications by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Prescription Pain Medications by Country/Region, 2018, 2022 & 2029
2.2 Prescription Pain Medications Segment by Type
2.2.1 Prescription NSAIDs
2.2.2 Opioids
2.2.3 Anti-epileptic Medicines
2.2.4 Antidepressants
2.2.5 Others
2.3 Prescription Pain Medications Sales by Type
2.3.1 Global Prescription Pain Medications Sales Market Share by Type (2018-2023)
2.3.2 Global Prescription Pain Medications Revenue and Market Share by Type (2018-2023)
2.3.3 Global Prescription Pain Medications Sale Price by Type (2018-2023)
2.4 Prescription Pain Medications Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstores
2.4.4 Others
2.5 Prescription Pain Medications Sales by Application
2.5.1 Global Prescription Pain Medications Sale Market Share by Application (2018-2023)
2.5.2 Global Prescription Pain Medications Revenue and Market Share by Application (2018-2023)
2.5.3 Global Prescription Pain Medications Sale Price by Application (2018-2023)
3 GLOBAL PRESCRIPTION PAIN MEDICATIONS BY COMPANY
3.1 Global Prescription Pain Medications Breakdown Data by Company
3.1.1 Global Prescription Pain Medications Annual Sales by Company (2018-2023)
3.1.2 Global Prescription Pain Medications Sales Market Share by Company (2018-2023)
3.2 Global Prescription Pain Medications Annual Revenue by Company (2018-2023)
3.2.1 Global Prescription Pain Medications Revenue by Company (2018-2023)
3.2.2 Global Prescription Pain Medications Revenue Market Share by Company (2018-2023)
3.3 Global Prescription Pain Medications Sale Price by Company
3.4 Key Manufacturers Prescription Pain Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Pain Medications Product Location Distribution
3.4.2 Players Prescription Pain Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PRESCRIPTION PAIN MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Prescription Pain Medications Market Size by Geographic Region (2018-2023)
4.1.1 Global Prescription Pain Medications Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Prescription Pain Medications Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Prescription Pain Medications Market Size by Country/Region (2018-2023)
4.2.1 Global Prescription Pain Medications Annual Sales by Country/Region (2018-2023)
4.2.2 Global Prescription Pain Medications Annual Revenue by Country/Region (2018-2023)
4.3 Americas Prescription Pain Medications Sales Growth
4.4 APAC Prescription Pain Medications Sales Growth
4.5 Europe Prescription Pain Medications Sales Growth
4.6 Middle East & Africa Prescription Pain Medications Sales Growth
5 AMERICAS
5.1 Americas Prescription Pain Medications Sales by Country
5.1.1 Americas Prescription Pain Medications Sales by Country (2018-2023)
5.1.2 Americas Prescription Pain Medications Revenue by Country (2018-2023)
5.2 Americas Prescription Pain Medications Sales by Type
5.3 Americas Prescription Pain Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Pain Medications Sales by Region
6.1.1 APAC Prescription Pain Medications Sales by Region (2018-2023)
6.1.2 APAC Prescription Pain Medications Revenue by Region (2018-2023)
6.2 APAC Prescription Pain Medications Sales by Type
6.3 APAC Prescription Pain Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prescription Pain Medications by Country
7.1.1 Europe Prescription Pain Medications Sales by Country (2018-2023)
7.1.2 Europe Prescription Pain Medications Revenue by Country (2018-2023)
7.2 Europe Prescription Pain Medications Sales by Type
7.3 Europe Prescription Pain Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prescription Pain Medications by Country
8.1.1 Middle East & Africa Prescription Pain Medications Sales by Country (2018-2023)
8.1.2 Middle East & Africa Prescription Pain Medications Revenue by Country (2018-2023)
8.2 Middle East & Africa Prescription Pain Medications Sales by Type
8.3 Middle East & Africa Prescription Pain Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Pain Medications
10.3 Manufacturing Process Analysis of Prescription Pain Medications
10.4 Industry Chain Structure of Prescription Pain Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prescription Pain Medications Distributors
11.3 Prescription Pain Medications Customer
12 WORLD FORECAST REVIEW FOR PRESCRIPTION PAIN MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Prescription Pain Medications Market Size Forecast by Region
12.1.1 Global Prescription Pain Medications Forecast by Region (2024-2029)
12.1.2 Global Prescription Pain Medications Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prescription Pain Medications Forecast by Type
12.7 Global Prescription Pain Medications Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Prescription Pain Medications Product Portfolios and Specifications
13.1.3 Pfizer Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Prescription Pain Medications Product Portfolios and Specifications
13.2.3 GSK Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Grunenthal
13.3.1 Grunenthal Company Information
13.3.2 Grunenthal Prescription Pain Medications Product Portfolios and Specifications
13.3.3 Grunenthal Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grunenthal Main Business Overview
13.3.5 Grunenthal Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Prescription Pain Medications Product Portfolios and Specifications
13.4.3 Bayer Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Prescription Pain Medications Product Portfolios and Specifications
13.5.3 Sanofi Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Prescription Pain Medications Product Portfolios and Specifications
13.6.3 Eli Lilly Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Prescription Pain Medications Product Portfolios and Specifications
13.7.3 AstraZeneca Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Endo
13.8.1 Endo Company Information
13.8.2 Endo Prescription Pain Medications Product Portfolios and Specifications
13.8.3 Endo Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Endo Main Business Overview
13.8.5 Endo Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Prescription Pain Medications Product Portfolios and Specifications
13.9.3 Merck Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Depomed
13.10.1 Depomed Company Information
13.10.2 Depomed Prescription Pain Medications Product Portfolios and Specifications
13.10.3 Depomed Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Depomed Main Business Overview
13.10.5 Depomed Latest Developments
13.11 Teva
13.11.1 Teva Company Information
13.11.2 Teva Prescription Pain Medications Product Portfolios and Specifications
13.11.3 Teva Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Teva Main Business Overview
13.11.5 Teva Latest Developments
13.12 J&J
13.12.1 J&J Company Information
13.12.2 J&J Prescription Pain Medications Product Portfolios and Specifications
13.12.3 J&J Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 J&J Main Business Overview
13.12.5 J&J Latest Developments
13.13 Allergan
13.13.1 Allergan Company Information
13.13.2 Allergan Prescription Pain Medications Product Portfolios and Specifications
13.13.3 Allergan Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Allergan Main Business Overview
13.13.5 Allergan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prescription Pain Medications Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Prescription Pain Medications by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Prescription Pain Medications by Country/Region, 2018, 2022 & 2029
2.2 Prescription Pain Medications Segment by Type
2.2.1 Prescription NSAIDs
2.2.2 Opioids
2.2.3 Anti-epileptic Medicines
2.2.4 Antidepressants
2.2.5 Others
2.3 Prescription Pain Medications Sales by Type
2.3.1 Global Prescription Pain Medications Sales Market Share by Type (2018-2023)
2.3.2 Global Prescription Pain Medications Revenue and Market Share by Type (2018-2023)
2.3.3 Global Prescription Pain Medications Sale Price by Type (2018-2023)
2.4 Prescription Pain Medications Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstores
2.4.4 Others
2.5 Prescription Pain Medications Sales by Application
2.5.1 Global Prescription Pain Medications Sale Market Share by Application (2018-2023)
2.5.2 Global Prescription Pain Medications Revenue and Market Share by Application (2018-2023)
2.5.3 Global Prescription Pain Medications Sale Price by Application (2018-2023)
3 GLOBAL PRESCRIPTION PAIN MEDICATIONS BY COMPANY
3.1 Global Prescription Pain Medications Breakdown Data by Company
3.1.1 Global Prescription Pain Medications Annual Sales by Company (2018-2023)
3.1.2 Global Prescription Pain Medications Sales Market Share by Company (2018-2023)
3.2 Global Prescription Pain Medications Annual Revenue by Company (2018-2023)
3.2.1 Global Prescription Pain Medications Revenue by Company (2018-2023)
3.2.2 Global Prescription Pain Medications Revenue Market Share by Company (2018-2023)
3.3 Global Prescription Pain Medications Sale Price by Company
3.4 Key Manufacturers Prescription Pain Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Pain Medications Product Location Distribution
3.4.2 Players Prescription Pain Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PRESCRIPTION PAIN MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Prescription Pain Medications Market Size by Geographic Region (2018-2023)
4.1.1 Global Prescription Pain Medications Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Prescription Pain Medications Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Prescription Pain Medications Market Size by Country/Region (2018-2023)
4.2.1 Global Prescription Pain Medications Annual Sales by Country/Region (2018-2023)
4.2.2 Global Prescription Pain Medications Annual Revenue by Country/Region (2018-2023)
4.3 Americas Prescription Pain Medications Sales Growth
4.4 APAC Prescription Pain Medications Sales Growth
4.5 Europe Prescription Pain Medications Sales Growth
4.6 Middle East & Africa Prescription Pain Medications Sales Growth
5 AMERICAS
5.1 Americas Prescription Pain Medications Sales by Country
5.1.1 Americas Prescription Pain Medications Sales by Country (2018-2023)
5.1.2 Americas Prescription Pain Medications Revenue by Country (2018-2023)
5.2 Americas Prescription Pain Medications Sales by Type
5.3 Americas Prescription Pain Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Pain Medications Sales by Region
6.1.1 APAC Prescription Pain Medications Sales by Region (2018-2023)
6.1.2 APAC Prescription Pain Medications Revenue by Region (2018-2023)
6.2 APAC Prescription Pain Medications Sales by Type
6.3 APAC Prescription Pain Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prescription Pain Medications by Country
7.1.1 Europe Prescription Pain Medications Sales by Country (2018-2023)
7.1.2 Europe Prescription Pain Medications Revenue by Country (2018-2023)
7.2 Europe Prescription Pain Medications Sales by Type
7.3 Europe Prescription Pain Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prescription Pain Medications by Country
8.1.1 Middle East & Africa Prescription Pain Medications Sales by Country (2018-2023)
8.1.2 Middle East & Africa Prescription Pain Medications Revenue by Country (2018-2023)
8.2 Middle East & Africa Prescription Pain Medications Sales by Type
8.3 Middle East & Africa Prescription Pain Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Pain Medications
10.3 Manufacturing Process Analysis of Prescription Pain Medications
10.4 Industry Chain Structure of Prescription Pain Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prescription Pain Medications Distributors
11.3 Prescription Pain Medications Customer
12 WORLD FORECAST REVIEW FOR PRESCRIPTION PAIN MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Prescription Pain Medications Market Size Forecast by Region
12.1.1 Global Prescription Pain Medications Forecast by Region (2024-2029)
12.1.2 Global Prescription Pain Medications Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prescription Pain Medications Forecast by Type
12.7 Global Prescription Pain Medications Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Prescription Pain Medications Product Portfolios and Specifications
13.1.3 Pfizer Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Prescription Pain Medications Product Portfolios and Specifications
13.2.3 GSK Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Grunenthal
13.3.1 Grunenthal Company Information
13.3.2 Grunenthal Prescription Pain Medications Product Portfolios and Specifications
13.3.3 Grunenthal Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grunenthal Main Business Overview
13.3.5 Grunenthal Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Prescription Pain Medications Product Portfolios and Specifications
13.4.3 Bayer Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Prescription Pain Medications Product Portfolios and Specifications
13.5.3 Sanofi Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Prescription Pain Medications Product Portfolios and Specifications
13.6.3 Eli Lilly Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Prescription Pain Medications Product Portfolios and Specifications
13.7.3 AstraZeneca Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Endo
13.8.1 Endo Company Information
13.8.2 Endo Prescription Pain Medications Product Portfolios and Specifications
13.8.3 Endo Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Endo Main Business Overview
13.8.5 Endo Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Prescription Pain Medications Product Portfolios and Specifications
13.9.3 Merck Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Depomed
13.10.1 Depomed Company Information
13.10.2 Depomed Prescription Pain Medications Product Portfolios and Specifications
13.10.3 Depomed Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Depomed Main Business Overview
13.10.5 Depomed Latest Developments
13.11 Teva
13.11.1 Teva Company Information
13.11.2 Teva Prescription Pain Medications Product Portfolios and Specifications
13.11.3 Teva Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Teva Main Business Overview
13.11.5 Teva Latest Developments
13.12 J&J
13.12.1 J&J Company Information
13.12.2 J&J Prescription Pain Medications Product Portfolios and Specifications
13.12.3 J&J Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 J&J Main Business Overview
13.12.5 J&J Latest Developments
13.13 Allergan
13.13.1 Allergan Company Information
13.13.2 Allergan Prescription Pain Medications Product Portfolios and Specifications
13.13.3 Allergan Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Allergan Main Business Overview
13.13.5 Allergan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prescription Pain Medications Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Prescription Pain Medications Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prescription NSAIDs
Table 4. Major Players of Opioids
Table 5. Major Players of Anti-epileptic Medicines
Table 6. Major Players of Antidepressants
Table 7. Major Players of Others
Table 8. Global Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 9. Global Prescription Pain Medications Sales Market Share by Type (2018-2023)
Table 10. Global Prescription Pain Medications Revenue by Type (2018-2023) & ($ million)
Table 11. Global Prescription Pain Medications Revenue Market Share by Type (2018-2023)
Table 12. Global Prescription Pain Medications Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 14. Global Prescription Pain Medications Sales Market Share by Application (2018-2023)
Table 15. Global Prescription Pain Medications Revenue by Application (2018-2023)
Table 16. Global Prescription Pain Medications Revenue Market Share by Application (2018-2023)
Table 17. Global Prescription Pain Medications Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Prescription Pain Medications Sales by Company (2018-2023) & (K Units)
Table 19. Global Prescription Pain Medications Sales Market Share by Company (2018-2023)
Table 20. Global Prescription Pain Medications Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Prescription Pain Medications Revenue Market Share by Company (2018-2023)
Table 22. Global Prescription Pain Medications Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Prescription Pain Medications Producing Area Distribution and Sales Area
Table 24. Players Prescription Pain Medications Products Offered
Table 25. Prescription Pain Medications Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Prescription Pain Medications Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Prescription Pain Medications Sales Market Share Geographic Region (2018-2023)
Table 30. Global Prescription Pain Medications Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Prescription Pain Medications Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Prescription Pain Medications Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Prescription Pain Medications Sales Market Share by Country/Region (2018-2023)
Table 34. Global Prescription Pain Medications Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Prescription Pain Medications Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Prescription Pain Medications Sales by Country (2018-2023) & (K Units)
Table 37. Americas Prescription Pain Medications Sales Market Share by Country (2018-2023)
Table 38. Americas Prescription Pain Medications Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Prescription Pain Medications Revenue Market Share by Country (2018-2023)
Table 40. Americas Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 41. Americas Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 42. APAC Prescription Pain Medications Sales by Region (2018-2023) & (K Units)
Table 43. APAC Prescription Pain Medications Sales Market Share by Region (2018-2023)
Table 44. APAC Prescription Pain Medications Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Prescription Pain Medications Revenue Market Share by Region (2018-2023)
Table 46. APAC Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 47. APAC Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 48. Europe Prescription Pain Medications Sales by Country (2018-2023) & (K Units)
Table 49. Europe Prescription Pain Medications Sales Market Share by Country (2018-2023)
Table 50. Europe Prescription Pain Medications Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Prescription Pain Medications Revenue Market Share by Country (2018-2023)
Table 52. Europe Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 53. Europe Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Prescription Pain Medications Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Prescription Pain Medications Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Prescription Pain Medications Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Prescription Pain Medications
Table 61. Key Market Challenges & Risks of Prescription Pain Medications
Table 62. Key Industry Trends of Prescription Pain Medications
Table 63. Prescription Pain Medications Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Prescription Pain Medications Distributors List
Table 66. Prescription Pain Medications Customer List
Table 67. Global Prescription Pain Medications Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Prescription Pain Medications Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Prescription Pain Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Prescription Pain Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Prescription Pain Medications Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Prescription Pain Medications Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Prescription Pain Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Prescription Pain Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Prescription Pain Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Prescription Pain Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Prescription Pain Medications Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Prescription Pain Medications Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Prescription Pain Medications Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Prescription Pain Medications Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Pfizer Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer Prescription Pain Medications Product Portfolios and Specifications
Table 83. Pfizer Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Pfizer Main Business
Table 85. Pfizer Latest Developments
Table 86. GSK Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 87. GSK Prescription Pain Medications Product Portfolios and Specifications
Table 88. GSK Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. GSK Main Business
Table 90. GSK Latest Developments
Table 91. Grunenthal Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 92. Grunenthal Prescription Pain Medications Product Portfolios and Specifications
Table 93. Grunenthal Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Grunenthal Main Business
Table 95. Grunenthal Latest Developments
Table 96. Bayer Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 97. Bayer Prescription Pain Medications Product Portfolios and Specifications
Table 98. Bayer Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Bayer Main Business
Table 100. Bayer Latest Developments
Table 101. Sanofi Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 102. Sanofi Prescription Pain Medications Product Portfolios and Specifications
Table 103. Sanofi Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Sanofi Main Business
Table 105. Sanofi Latest Developments
Table 106. Eli Lilly Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 107. Eli Lilly Prescription Pain Medications Product Portfolios and Specifications
Table 108. Eli Lilly Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Eli Lilly Main Business
Table 110. Eli Lilly Latest Developments
Table 111. AstraZeneca Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 112. AstraZeneca Prescription Pain Medications Product Portfolios and Specifications
Table 113. AstraZeneca Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. AstraZeneca Main Business
Table 115. AstraZeneca Latest Developments
Table 116. Endo Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 117. Endo Prescription Pain Medications Product Portfolios and Specifications
Table 118. Endo Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Endo Main Business
Table 120. Endo Latest Developments
Table 121. Merck Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 122. Merck Prescription Pain Medications Product Portfolios and Specifications
Table 123. Merck Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Merck Main Business
Table 125. Merck Latest Developments
Table 126. Depomed Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 127. Depomed Prescription Pain Medications Product Portfolios and Specifications
Table 128. Depomed Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Depomed Main Business
Table 130. Depomed Latest Developments
Table 131. Teva Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 132. Teva Prescription Pain Medications Product Portfolios and Specifications
Table 133. Teva Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Teva Main Business
Table 135. Teva Latest Developments
Table 136. J&J Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 137. J&J Prescription Pain Medications Product Portfolios and Specifications
Table 138. J&J Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. J&J Main Business
Table 140. J&J Latest Developments
Table 141. Allergan Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 142. Allergan Prescription Pain Medications Product Portfolios and Specifications
Table 143. Allergan Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Allergan Main Business
Table 145. Allergan Latest Developments
Table 1. Prescription Pain Medications Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Prescription Pain Medications Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prescription NSAIDs
Table 4. Major Players of Opioids
Table 5. Major Players of Anti-epileptic Medicines
Table 6. Major Players of Antidepressants
Table 7. Major Players of Others
Table 8. Global Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 9. Global Prescription Pain Medications Sales Market Share by Type (2018-2023)
Table 10. Global Prescription Pain Medications Revenue by Type (2018-2023) & ($ million)
Table 11. Global Prescription Pain Medications Revenue Market Share by Type (2018-2023)
Table 12. Global Prescription Pain Medications Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 14. Global Prescription Pain Medications Sales Market Share by Application (2018-2023)
Table 15. Global Prescription Pain Medications Revenue by Application (2018-2023)
Table 16. Global Prescription Pain Medications Revenue Market Share by Application (2018-2023)
Table 17. Global Prescription Pain Medications Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Prescription Pain Medications Sales by Company (2018-2023) & (K Units)
Table 19. Global Prescription Pain Medications Sales Market Share by Company (2018-2023)
Table 20. Global Prescription Pain Medications Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Prescription Pain Medications Revenue Market Share by Company (2018-2023)
Table 22. Global Prescription Pain Medications Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Prescription Pain Medications Producing Area Distribution and Sales Area
Table 24. Players Prescription Pain Medications Products Offered
Table 25. Prescription Pain Medications Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Prescription Pain Medications Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Prescription Pain Medications Sales Market Share Geographic Region (2018-2023)
Table 30. Global Prescription Pain Medications Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Prescription Pain Medications Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Prescription Pain Medications Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Prescription Pain Medications Sales Market Share by Country/Region (2018-2023)
Table 34. Global Prescription Pain Medications Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Prescription Pain Medications Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Prescription Pain Medications Sales by Country (2018-2023) & (K Units)
Table 37. Americas Prescription Pain Medications Sales Market Share by Country (2018-2023)
Table 38. Americas Prescription Pain Medications Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Prescription Pain Medications Revenue Market Share by Country (2018-2023)
Table 40. Americas Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 41. Americas Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 42. APAC Prescription Pain Medications Sales by Region (2018-2023) & (K Units)
Table 43. APAC Prescription Pain Medications Sales Market Share by Region (2018-2023)
Table 44. APAC Prescription Pain Medications Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Prescription Pain Medications Revenue Market Share by Region (2018-2023)
Table 46. APAC Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 47. APAC Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 48. Europe Prescription Pain Medications Sales by Country (2018-2023) & (K Units)
Table 49. Europe Prescription Pain Medications Sales Market Share by Country (2018-2023)
Table 50. Europe Prescription Pain Medications Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Prescription Pain Medications Revenue Market Share by Country (2018-2023)
Table 52. Europe Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 53. Europe Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Prescription Pain Medications Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Prescription Pain Medications Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Prescription Pain Medications Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Prescription Pain Medications Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Prescription Pain Medications Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Prescription Pain Medications
Table 61. Key Market Challenges & Risks of Prescription Pain Medications
Table 62. Key Industry Trends of Prescription Pain Medications
Table 63. Prescription Pain Medications Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Prescription Pain Medications Distributors List
Table 66. Prescription Pain Medications Customer List
Table 67. Global Prescription Pain Medications Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Prescription Pain Medications Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Prescription Pain Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Prescription Pain Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Prescription Pain Medications Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Prescription Pain Medications Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Prescription Pain Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Prescription Pain Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Prescription Pain Medications Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Prescription Pain Medications Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Prescription Pain Medications Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Prescription Pain Medications Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Prescription Pain Medications Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Prescription Pain Medications Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Pfizer Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer Prescription Pain Medications Product Portfolios and Specifications
Table 83. Pfizer Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Pfizer Main Business
Table 85. Pfizer Latest Developments
Table 86. GSK Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 87. GSK Prescription Pain Medications Product Portfolios and Specifications
Table 88. GSK Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. GSK Main Business
Table 90. GSK Latest Developments
Table 91. Grunenthal Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 92. Grunenthal Prescription Pain Medications Product Portfolios and Specifications
Table 93. Grunenthal Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Grunenthal Main Business
Table 95. Grunenthal Latest Developments
Table 96. Bayer Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 97. Bayer Prescription Pain Medications Product Portfolios and Specifications
Table 98. Bayer Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Bayer Main Business
Table 100. Bayer Latest Developments
Table 101. Sanofi Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 102. Sanofi Prescription Pain Medications Product Portfolios and Specifications
Table 103. Sanofi Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Sanofi Main Business
Table 105. Sanofi Latest Developments
Table 106. Eli Lilly Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 107. Eli Lilly Prescription Pain Medications Product Portfolios and Specifications
Table 108. Eli Lilly Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Eli Lilly Main Business
Table 110. Eli Lilly Latest Developments
Table 111. AstraZeneca Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 112. AstraZeneca Prescription Pain Medications Product Portfolios and Specifications
Table 113. AstraZeneca Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. AstraZeneca Main Business
Table 115. AstraZeneca Latest Developments
Table 116. Endo Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 117. Endo Prescription Pain Medications Product Portfolios and Specifications
Table 118. Endo Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Endo Main Business
Table 120. Endo Latest Developments
Table 121. Merck Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 122. Merck Prescription Pain Medications Product Portfolios and Specifications
Table 123. Merck Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Merck Main Business
Table 125. Merck Latest Developments
Table 126. Depomed Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 127. Depomed Prescription Pain Medications Product Portfolios and Specifications
Table 128. Depomed Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Depomed Main Business
Table 130. Depomed Latest Developments
Table 131. Teva Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 132. Teva Prescription Pain Medications Product Portfolios and Specifications
Table 133. Teva Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Teva Main Business
Table 135. Teva Latest Developments
Table 136. J&J Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 137. J&J Prescription Pain Medications Product Portfolios and Specifications
Table 138. J&J Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. J&J Main Business
Table 140. J&J Latest Developments
Table 141. Allergan Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 142. Allergan Prescription Pain Medications Product Portfolios and Specifications
Table 143. Allergan Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Allergan Main Business
Table 145. Allergan Latest Developments
LIST OF FIGURES
Figure 1. Picture of Prescription Pain Medications
Figure 2. Prescription Pain Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Pain Medications Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Prescription Pain Medications Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Prescription Pain Medications Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prescription NSAIDs
Figure 10. Product Picture of Opioids
Figure 11. Product Picture of Anti-epileptic Medicines
Figure 12. Product Picture of Antidepressants
Figure 13. Product Picture of Others
Figure 14. Global Prescription Pain Medications Sales Market Share by Type in 2022
Figure 15. Global Prescription Pain Medications Revenue Market Share by Type (2018-2023)
Figure 16. Prescription Pain Medications Consumed in Hospitals
Figure 17. Global Prescription Pain Medications Market: Hospitals (2018-2023) & (K Units)
Figure 18. Prescription Pain Medications Consumed in Clinics
Figure 19. Global Prescription Pain Medications Market: Clinics (2018-2023) & (K Units)
Figure 20. Prescription Pain Medications Consumed in Drugstores
Figure 21. Global Prescription Pain Medications Market: Drugstores (2018-2023) & (K Units)
Figure 22. Prescription Pain Medications Consumed in Others
Figure 23. Global Prescription Pain Medications Market: Others (2018-2023) & (K Units)
Figure 24. Global Prescription Pain Medications Sales Market Share by Application (2022)
Figure 25. Global Prescription Pain Medications Revenue Market Share by Application in 2022
Figure 26. Prescription Pain Medications Sales Market by Company in 2022 (K Units)
Figure 27. Global Prescription Pain Medications Sales Market Share by Company in 2022
Figure 28. Prescription Pain Medications Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Prescription Pain Medications Revenue Market Share by Company in 2022
Figure 30. Global Prescription Pain Medications Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Prescription Pain Medications Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Prescription Pain Medications Sales 2018-2023 (K Units)
Figure 33. Americas Prescription Pain Medications Revenue 2018-2023 ($ Millions)
Figure 34. APAC Prescription Pain Medications Sales 2018-2023 (K Units)
Figure 35. APAC Prescription Pain Medications Revenue 2018-2023 ($ Millions)
Figure 36. Europe Prescription Pain Medications Sales 2018-2023 (K Units)
Figure 37. Europe Prescription Pain Medications Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Prescription Pain Medications Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Prescription Pain Medications Revenue 2018-2023 ($ Millions)
Figure 40. Americas Prescription Pain Medications Sales Market Share by Country in 2022
Figure 41. Americas Prescription Pain Medications Revenue Market Share by Country in 2022
Figure 42. Americas Prescription Pain Medications Sales Market Share by Type (2018-2023)
Figure 43. Americas Prescription Pain Medications Sales Market Share by Application (2018-2023)
Figure 44. United States Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Prescription Pain Medications Sales Market Share by Region in 2022
Figure 49. APAC Prescription Pain Medications Revenue Market Share by Regions in 2022
Figure 50. APAC Prescription Pain Medications Sales Market Share by Type (2018-2023)
Figure 51. APAC Prescription Pain Medications Sales Market Share by Application (2018-2023)
Figure 52. China Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Prescription Pain Medications Sales Market Share by Country in 2022
Figure 60. Europe Prescription Pain Medications Revenue Market Share by Country in 2022
Figure 61. Europe Prescription Pain Medications Sales Market Share by Type (2018-2023)
Figure 62. Europe Prescription Pain Medications Sales Market Share by Application (2018-2023)
Figure 63. Germany Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Prescription Pain Medications Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Prescription Pain Medications Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Prescription Pain Medications Sales Market Share by Application (2018-2023)
Figure 72. Egypt Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Prescription Pain Medications in 2022
Figure 78. Manufacturing Process Analysis of Prescription Pain Medications
Figure 79. Industry Chain Structure of Prescription Pain Medications
Figure 80. Channels of Distribution
Figure 81. Global Prescription Pain Medications Sales Market Forecast by Region (2024-2029)
Figure 82. Global Prescription Pain Medications Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Prescription Pain Medications Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Prescription Pain Medications Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Prescription Pain Medications Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Prescription Pain Medications Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Prescription Pain Medications
Figure 2. Prescription Pain Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Pain Medications Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Prescription Pain Medications Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Prescription Pain Medications Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prescription NSAIDs
Figure 10. Product Picture of Opioids
Figure 11. Product Picture of Anti-epileptic Medicines
Figure 12. Product Picture of Antidepressants
Figure 13. Product Picture of Others
Figure 14. Global Prescription Pain Medications Sales Market Share by Type in 2022
Figure 15. Global Prescription Pain Medications Revenue Market Share by Type (2018-2023)
Figure 16. Prescription Pain Medications Consumed in Hospitals
Figure 17. Global Prescription Pain Medications Market: Hospitals (2018-2023) & (K Units)
Figure 18. Prescription Pain Medications Consumed in Clinics
Figure 19. Global Prescription Pain Medications Market: Clinics (2018-2023) & (K Units)
Figure 20. Prescription Pain Medications Consumed in Drugstores
Figure 21. Global Prescription Pain Medications Market: Drugstores (2018-2023) & (K Units)
Figure 22. Prescription Pain Medications Consumed in Others
Figure 23. Global Prescription Pain Medications Market: Others (2018-2023) & (K Units)
Figure 24. Global Prescription Pain Medications Sales Market Share by Application (2022)
Figure 25. Global Prescription Pain Medications Revenue Market Share by Application in 2022
Figure 26. Prescription Pain Medications Sales Market by Company in 2022 (K Units)
Figure 27. Global Prescription Pain Medications Sales Market Share by Company in 2022
Figure 28. Prescription Pain Medications Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Prescription Pain Medications Revenue Market Share by Company in 2022
Figure 30. Global Prescription Pain Medications Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Prescription Pain Medications Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Prescription Pain Medications Sales 2018-2023 (K Units)
Figure 33. Americas Prescription Pain Medications Revenue 2018-2023 ($ Millions)
Figure 34. APAC Prescription Pain Medications Sales 2018-2023 (K Units)
Figure 35. APAC Prescription Pain Medications Revenue 2018-2023 ($ Millions)
Figure 36. Europe Prescription Pain Medications Sales 2018-2023 (K Units)
Figure 37. Europe Prescription Pain Medications Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Prescription Pain Medications Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Prescription Pain Medications Revenue 2018-2023 ($ Millions)
Figure 40. Americas Prescription Pain Medications Sales Market Share by Country in 2022
Figure 41. Americas Prescription Pain Medications Revenue Market Share by Country in 2022
Figure 42. Americas Prescription Pain Medications Sales Market Share by Type (2018-2023)
Figure 43. Americas Prescription Pain Medications Sales Market Share by Application (2018-2023)
Figure 44. United States Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Prescription Pain Medications Sales Market Share by Region in 2022
Figure 49. APAC Prescription Pain Medications Revenue Market Share by Regions in 2022
Figure 50. APAC Prescription Pain Medications Sales Market Share by Type (2018-2023)
Figure 51. APAC Prescription Pain Medications Sales Market Share by Application (2018-2023)
Figure 52. China Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Prescription Pain Medications Sales Market Share by Country in 2022
Figure 60. Europe Prescription Pain Medications Revenue Market Share by Country in 2022
Figure 61. Europe Prescription Pain Medications Sales Market Share by Type (2018-2023)
Figure 62. Europe Prescription Pain Medications Sales Market Share by Application (2018-2023)
Figure 63. Germany Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Prescription Pain Medications Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Prescription Pain Medications Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Prescription Pain Medications Sales Market Share by Application (2018-2023)
Figure 72. Egypt Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Prescription Pain Medications Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Prescription Pain Medications in 2022
Figure 78. Manufacturing Process Analysis of Prescription Pain Medications
Figure 79. Industry Chain Structure of Prescription Pain Medications
Figure 80. Channels of Distribution
Figure 81. Global Prescription Pain Medications Sales Market Forecast by Region (2024-2029)
Figure 82. Global Prescription Pain Medications Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Prescription Pain Medications Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Prescription Pain Medications Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Prescription Pain Medications Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Prescription Pain Medications Revenue Market Share Forecast by Application (2024-2029)
